1 / 50

Hot Topics in Lymphoma Supportive Care

Hot Topics in Lymphoma Supportive Care. Program Goal. Program Overview. Lenalidomide. Lenalidomide Toxicities. Lenalidomide-Associated Tumor Flare Reaction. Management of Tumor Flare Reaction. Bendamustine. Bendamustine-Associated Toxicities. Skin Reactions. Managing Skin Reactions.

eithne
Download Presentation

Hot Topics in Lymphoma Supportive Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hot Topics in Lymphoma Supportive Care

  2. Program Goal

  3. Program Overview

  4. Lenalidomide

  5. Lenalidomide Toxicities

  6. Lenalidomide-Associated Tumor Flare Reaction

  7. Management of Tumor Flare Reaction

  8. Bendamustine

  9. Bendamustine-Associated Toxicities

  10. Skin Reactions

  11. Managing Skin Reactions

  12. PI3K Delta and BTK Inhibition in B-Cell Neoplasms

  13. B-Cell Receptor Pathway Inhibitors: Peripheral Lymphocytosis

  14. Ibrutinib Monotherapy in Relapsed/Refractory CLL/SLL

  15. Ibrutinib Monotherapy in Relapsed/Refractory MCL

  16. Idelalisib (GS-1101, CAL-101)

  17. Brentuximab Vedotin

  18. Brentuximab Vedotin Toxicities

  19. Delayed-Onset Neutropenia After Rituximab

  20. Rituximab-Associated Hypogammaglobulinemia

  21. Rituximab-Associated Hypogammaglobulinemia (cont)

  22. Hepatitis B Viral Reactivation

  23. PML: Viral Reactivation of JC Virus

  24. PML: Findings of the RADAR Project

  25. Causes of PML

  26. Diagnosing PML

  27. Tumor Lysis Syndrome

  28. Definition of Clinical TLS

  29. Management of TLS

  30. Hyperuricemia: Allopurinol

  31. Hyperuricemia: Rasburicase

  32. Limitations of Rasburicase

  33. Cancer-Related Fatigue

  34. Management of Cancer-Related Fatigue

  35. Reporting Adverse Effects

  36. Abbreviations

  37. Abbreviations (cont)

  38. Abbreviations (cont)

  39. References

  40. References (cont)

  41. References (cont)

  42. References (cont)

  43. References (cont)

  44. References (cont)

  45. References (cont)

  46. References (cont)

  47. References (cont)

  48. References (cont)

More Related